| 685438 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Inhibitory Effect of Lactococcus lactis subsp. lactis HFY14 on Diphenoxylate-Induced Constipation in Mice by Regulating the VIP-cAMP-PKA-AQP3 Signaling Pathway |
2021-05-01 |
10.2147/dddt.s309675 |
Tan Qian, Hu Jing, Zhou Yujing, Wan Yunxiao, Zhang Chuanlan, Liu Xin, Long Xingyao, Tan Fang, Zhao Xin |
| 685437 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis |
2021-05-01 |
10.2147/dddt.s300376 |
Zhang Hui, Li Minghui, Zhang Jing, Shen Yanbing, Gui Qi |
| 685436 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure |
2021-05-01 |
10.2147/dddt.s308863 |
Badary Osama, Hamza Marwa S, Tikamdas Rajiv |
| 685435 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Forkhead Box Protein O1: Functional Diversity and Post-Translational Modification, a New Therapeutic Target? |
2021-05-01 |
10.2147/dddt.s305016 |
Zhang Xiaojun, Jiang Lusheng, Liu Huimin |
| 685434 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study |
2021-05-01 |
10.2147/dddt.s304857 |
Li Hui, Qin Shukui, Liu Ying, Chen Zhendong, Ren Zhenggang, Xiong Jianping, Meng Zhiqiang, Zhang Xiao, Wang Linna, Zhang Xiaojing, Zou Jianjun |
| 685433 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach |
2021-05-01 |
10.2147/dddt.s240506 |
Kanwal Ummarah, Mukhtar Shahid, Waheed Muzzamil, Mehreen Arifa, Abbas Nasir, Shamim Rahat, Hussain Khalid, Rasool Fatima, Hussain Amjad, Bukhari Nadeem Irfan |
| 685432 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice |
2021-05-01 |
10.2147/dddt.s285828 |
Li Huashan, Sheng Jianying, Wang Jing, Gao Haiting, Yu Jing, Ding Guoxian, Ding Ning, He Weiqi, Zha Juanmin |
| 685431 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway |
2021-05-01 |
10.2147/dddt.s306367 |
Zhao Yingnan, Li Yanping, Liu Qinhui, Tang Qin, Zhang Zijing, Zhang Jinhang, Huang Cuiyuan, Huang Hui, Zhang Guorong, Zhou Jian, Yan Jiamin, Xia Yan, Zhang Zhiyong, He Jinhan |
| 685430 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
The Abuse Characteristics of Amphetamine-Type Stimulants in Patients Receiving Methadone Maintenance Treatment and Buprenorphine Maintenance Treatment |
2021-05-01 |
10.2147/dddt.s305226 |
Liu Yue, Liu Nina, Shen Wenwen, Li Longhui, Zhou Wenhua, Xu Leiting |
| 685429 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Adjuvant Sufentanil Decreased the EC50 of Epidural Ropivacaine for Labor Analgesia in Healthy Term Pregnancy |
2021-05-01 |
10.2147/dddt.s307478 |
Xiang Bo, Yang Jian, Lei Xiaofeng, Yu Jin |
